Utilization of I-domain of LFA-1 to target drug and marker molecules to Leukocytes.
The long-term objective of this project is to utilize the I-domain protein for the α-subunit of LFA-1 to target drugs to lymphocytes by binding to ICAM receptors on the cell surface. The short-term goal is to provide proof-of-concept that I-domain conjugated to small molecules can still bind to and...
Main Authors: | Manikwar, Prakash, Tejo, Bimo Ario, Shinogle, Heather, Moore, David S., Zimmerman, Tahl, Blanco, Francisco, Siahaan, Teruna J. |
---|---|
Format: | Article |
Language: | English English |
Published: |
Ivyspring International Publisher
2011
|
Online Access: | http://psasir.upm.edu.my/id/eprint/25114/1/Utilization%20of%20I.pdf |
Similar Items
-
Utilization of I-domain of LFA-1 to Target Drug and Marker Molecules to Leukocytes
by: Prakash Manikwar, Bimo A. Tejo, Heather Shinogle, David S. Moore, Tahl Zimmerman, Francisco Blanco, Teruna J. Siahaan
Published: (2011-01-01) -
Solution structure of a novel T-cell adhesion inhibitor derived from the fragment of ICAM-1 receptor: cyclo(1,8)-Cys-Pro-Arg-Gly-Gly-Ser-Val-Cys
by: Tejo, Bimo Ario, et al.
Published: (2009) -
Effect of modification of the physicochemical properties of ICAM-1-derived peptides on internalization and intracellular distribution in the human leukemic cell line HL-60
by: Majumdar, Sumit, et al.
Published: (2009) -
Inhibition of junctional adhesion molecule-A/LFA interaction attenuates leukocyte trafficking and inflammation in brain ischemia/reperfusion injury
by: Nikola Sladojevic, et al.
Published: (2014-07-01) -
Direction of actin flow dictates integrin LFA-1 orientation during leukocyte migration
by: Pontus Nordenfelt, et al.
Published: (2017-12-01)